Two consecutive phase-II-studies of oxaliplatin (L-OHP) for treatment of patients with advanced colorectal carcinoma who were resistant to previous treatment with fluoropyrimidines. - Machover,D.; Diaz-Rubio,E.; de Gramont,A. (Ann Oncol, 1996)